Related Experiment Video
Updated: Dec 17, 2025

Home-Based Monitor for Gait and Activity Analysis
Published on: August 8, 2019
Development of a multivariable improvement measure for gout
Naomi Schlesinger1, N Lawrence Edwards2, Anthony E Yeo3
1Division of Rheumatology, Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
A new Gout Multivariable Improvement Measure (GMIM) effectively assesses gout treatment response. This tool, utilizing pegloticase, demonstrated significant improvements in patient outcomes and disease activity over time.
Area of Science:
- Rheumatology
- Clinical Trials
- Drug Efficacy
Background:
- Gout is a complex inflammatory condition with varied clinical presentations.
- A comprehensive method to evaluate gout therapy's impact across multiple disease aspects is needed.
Purpose of the Study:
- To assess the efficacy of pegloticase compared to placebo in gout patients.
- To evaluate a novel Gout Multivariable Improvement Measure (GMIM) for assessing treatment response.
Main Methods:
- A novel, evidence-based Gout Multivariable Improvement Measure (GMIM) was developed.
- Two randomized clinical trials and their open-label extension were analyzed.
- Improvement criteria included serum urate levels, flare absence, tophus size, patient global assessment, pain, and joint status.
Main Results:
- Pegloticase treatment resulted in significantly higher GMIM response rates compared to placebo.
- Persistent urate lowering correlated with higher GMIM response rates.
- GMIM responses were sustained for up to two years and comparable between initial pegloticase and later-treated groups.
Conclusions:
- The Gout Multivariable Improvement Measure (GMIM) effectively captures treatment-induced changes in gout disease activity.
- GMIM serves as a valuable, evidence-based tool for evaluating responses to urate-lowering therapies in gout management.
Related Concept Videos
Urinary Tract Calculi III: Medical Management
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Urinary Tract Calculi V: Nursing Management
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
Determination of Renal Drug Clearance: Graphical and Midpoint Methods
The graphical method involves plotting the rate of drug excretion in urine against the plasma drug concentration. By analyzing the graph, the clearance can be calculated and obtained. Drugs rapidly excreted by the kidneys exhibit a...

